Editorials What have we learnt from the rosiglitazone saga? BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d1354 (Published 17 March 2011) Cite this as: BMJ 2011;342:d1354 Article Related content Metrics Responses Peer review Related articles Research Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies Published: 17 March 2011; BMJ 342 doi:10.1136/bmj.d1309 Letter Should we throw the baby out with the bathwater? Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2566 Editorial Patient information on prescribed drugs Published: 03 May 2011; BMJ 342 doi:10.1136/bmj.d1924 Research Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis Published: 12 March 2012; BMJ 344 doi:10.1136/bmj.e1369 See more Why are UK cardiovascular deaths in under 65s rising again? BMJ May 19, 2025, 389 r1015; DOI: https://doi.org/10.1136/bmj.r1015 Prescribing parkrun: medicalising a walk in the park BMJ April 08, 2025, 389 r670; DOI: https://doi.org/10.1136/bmj.r670 GPs can prescribe tirzepatide to priority patient groups from June BMJ April 02, 2025, 389 r665; DOI: https://doi.org/10.1136/bmj.r665 Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reports BMJ February 12, 2025, 388 r287; DOI: https://doi.org/10.1136/bmj.r287 Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog finds BMJ November 13, 2024, 387 q2518; DOI: https://doi.org/10.1136/bmj.q2518 Cited by... Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysisAbstract Fulltext PDF State Medicaid Programs Did Not Make Use Of Prior Authorization To Promote Safer Prescribing After Rosiglitazone WarningAbstract Fulltext PDF Patient information on prescribed drugsAbstract Fulltext PDF Should we throw the baby out with the bathwater?Abstract Fulltext PDF Authors' replyAbstract Fulltext PDF Rosiglitazone vs. Pioglitazone -- What Are the Odds?Abstract Fulltext PDF
